Adam D. Cutler
CIK 1722673 · Chief Financial Officer · last filed 2025-12-05
Adam D. Cutler is a Chief Financial Officer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2017. The most recent filing, for MURAV, was dated Dec 5, 2025. Across all open-market trades the lifetime net is −$40.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
17
-$40.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MURAV | Chief Financial Officer | 0 | — | — | -$40.2K | 5 | 2025-12-05 |
| INM | Director | — | $1.51 | — | $0 | 3 | 2022-01-24 |
| Molecular Templates, Inc. (MTEM) Delisted | See remarks | — | $0.00 | — | $0 | 5 | 2021-02-17 |
| NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Director | 10,000 | $0.00 | $1 | $0 | 4 | 2021-01-14 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-05 | MURAV | Disp (D) | −99,290 | $0 | EDGAR |
| 2025-11-10 | MURAV | Sell (S) | −7,148 | -$14.9K | EDGAR |
| 2025-03-05 | MURAV | Grant (A) | +35,000 | $0 | EDGAR |
| 2024-11-01 | MURAV | Sell (S) | −7,421 | -$25.3K | EDGAR |
| 2023-12-18 | MURAV | Grant (A) | +78,859 | $0 | EDGAR |
| 2022-01-24 | INM | H | — | $0 | EDGAR |
| 2021-12-30 | INM | Grant (A) | — | $0 | EDGAR |
| 2021-02-17 | Molecular Templates, Inc. (MTEM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-14 | NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted | Grant (A) | +2,500 | $2 | EDGAR |
| 2020-12-18 | INM | Grant (A) | — | $0 | EDGAR |